PurePath™ Banned Ingredient
Risk Level: 
Medium

MSG

Chemical Identifier:
Sodium 2-aminopentanedioate

☡Risk Level Summary☡

The risk associated with MSG is primarily tied to its role as an Excitotoxin. While the body utilizes glutamate as a major excitatory neurotransmitter, many researchers argue that "free" glutamate—unbound from the protein matrix found in whole foods—crosses the blood-brain barrier more easily or overstimulates receptors in the hypothalamus. This can lead to cellular fatigue or "excitotoxicity," particularly in children or individuals with compromised neurological barriers.

Biological Impact & Mechanism

Neurotransmitter Stimulation: MSG provides a surge of free glutamate, which binds to NMDA and AMPA receptors in the brain. In sensitive individuals, this can cause "over-firing" of neurons.

Insulin Response: Emerging studies suggest that MSG may stimulate the pancreas to release insulin, even in the absence of carbohydrates, potentially contributing to metabolic syndrome or leptin resistance over time.

Leptin Interference: Some animal models show that MSG consumption can disrupt the arcuate nucleus in the brain, which regulates the hormone leptin, potentially leading to a lack of "fullness" signaling and subsequent overeating.

Historical & Common Use

MSG was discovered in 1908 by Japanese chemist Kikunae Ikeda, who isolated the substance from kelp (Kombu). He identified the taste as "Umami." By 1909, the Ajinomoto corporation began mass-producing MSG. It became a staple in military rations during WWII to make bland food palatable and was subsequently adopted by the burgeoning American fast-food and canned-soup industries in the 1950s.

Consumer Sentiments

Public sentiment is deeply fractured. For decades, MSG was plagued by "Chinese Restaurant Syndrome" stigmas, which many modern culinary experts decry as xenophobic or unscientific. However, a significant "clean eating" contingency remains staunchly anti-MSG, citing personal neurological reactions. In the restaurant industry, there is a push to "reclaim" MSG as a safe tool, while the health-conscious consumer market continues to drive a surge in "No MSG Added" labeling.

Consumer Reports of Health Effects and Symptoms

The "MSG Symptom Complex" includes frequent reports of:

   Neurological: Throbbing headaches (migraines), dizziness, and "brain fog."

   Dermatological: Flushing of the face, neck, and arms; excessive sweating.

   Cardiovascular: Palpitations or a rapid, fluttering heartbeat.

   Sensory: Numbness or tingling in the extremities and a feeling of pressure in the facial muscles.

FDA & Other Regulatory Authorities

FDA (USA): Classified as GRAS (Generally Recognized As Safe). As of 2026, the FDA maintains that most people can consume MSG without issue, though it mandates that MSG must be listed by its common name on labels. It cannot be hidden under "Spices" but can sometimes be part of "Natural Flavors" if the glutamate is naturally occurring in an extract.

EFSA (EU): In July 2017, EFSA established a "Group Acceptable Daily Intake" (ADI) for glutamates at 30 mg/kg of body weight per day. This was a significant shift, as previously there was no numerical limit.

WHO Western Pacific / JECFA: Consistently rates MSG as having a "not specified" ADI, meaning it is considered very low toxicity. However, WHO guidelines for the region emphasize reducing sodium intake, noting that MSG contributes to total sodium consumption (though it contains about 1/3 the sodium of table salt).

USDA: Permits the use of MSG in meat and poultry products but requires clear labeling on the package to ensure consumers are aware of its presence for sensitivity reasons.

The PurePath™ Standard Swap

Nutritional Yeast, Sea Salt, Tamari (Wheat-free), Shiitake Mushroom Powder, Dried Seaweed (Kombu), Anchovy Paste, Bone Broth.
Subscribe to MSG